MADD

MAP kinase activating death domain, the group of DENN domain containing

Basic information

Region (hg38): 11:47269161-47330031

Links

ENSG00000110514NCBI:8567OMIM:603584HGNC:6766Uniprot:Q8WXG6AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • neurodevelopmental disorder with dysmorphic facies, impaired speech, and hypotonia (Strong), mode of inheritance: AR
  • syndromic intellectual disability (Supportive), mode of inheritance: AD
  • neurodevelopmental disorder with dysmorphic facies, impaired speech, and hypotonia (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Developmental delay with endocrine, exocrine, autonomic, and hematologic abnormalities (DEEAH) syndromeAREndocrineAmong other findings, individuals have been described with endocrine anomalies (eg, hypoglycemia, thyroid dysfunction, growth hormone deficiency, and panhypopituitarism), and awareness may allow early diagnosis of medical management of these manifestationsCraniofacial; Endocrine; Hematologic; Musculoskeletal; Neurologic28940097; 32761064

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MADD gene.

  • not provided (2 variants)
  • MADD-related disorder (1 variants)
  • Deeah syndrome (1 variants)
  • Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type (1 variants)
  • Inborn genetic diseases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MADD gene is commonly pathogenic or not. These statistics are base on transcript: . Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
17
clinvar
3
clinvar
23
missense
1
clinvar
168
clinvar
2
clinvar
5
clinvar
176
nonsense
3
clinvar
7
clinvar
1
clinvar
11
start loss
0
frameshift
2
clinvar
3
clinvar
5
splice donor/acceptor (+/-2bp)
1
clinvar
4
clinvar
1
clinvar
6
Total 6 15 173 19 8

Highest pathogenic variant AF is 0.0000262802

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MADDprotein_codingprotein_codingENST00000311027 3560871
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.54e-141.0011619525592981257480.0387
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.108829790.9010.000059710823
Missense in Polyphen305418.810.728254603
Synonymous-0.3923903801.030.00002303260
Loss of Function4.873988.50.4410.00000523945

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.03180.0318
Ashkenazi Jewish0.03390.0341
East Asian0.0003280.000326
Finnish0.03900.0391
European (Non-Finnish)0.06170.0616
Middle Eastern0.0003280.000326
South Asian0.01410.0139
Other0.04040.0407

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays a significant role in regulating cell proliferation, survival and death through alternative mRNA splicing. Isoform 5 shows increased cell proliferation and isoform 2 shows decreased. Converts GDP-bound inactive form of RAB3A, RAB3C and RAB3D to the GTP-bound active forms. Component of the TNFRSF1A signaling complex: MADD links TNFRSF1A with MAP kinase activation. Plays an important regulatory role in physiological cell death (TNF-alpha-induced, caspase-mediated apoptosis); isoform 1 is susceptible to inducing apoptosis, isoform 5 is resistant and isoform 3 and isoform 4 have no effect. {ECO:0000269|PubMed:11577081, ECO:0000269|PubMed:14716293, ECO:0000269|PubMed:14735464, ECO:0000269|PubMed:15007167, ECO:0000269|PubMed:20937701, ECO:0000269|PubMed:9115275}.;
Pathway
Apoptosis Modulation and Signaling;Deregulation of Rab and Rab Effector Genes in Bladder Cancer;TNF alpha Signaling Pathway;Signal Transduction;Vesicle-mediated transport;tnfr1 signaling pathway;Membrane Trafficking;ceramide signaling pathway;TNF signaling;sodd/tnfr1 signaling pathway;Rab regulation of trafficking;Death Receptor Signalling;Regulation of TNFR1 signaling;RAB GEFs exchange GTP for GDP on RABs;Caspase Cascade in Apoptosis;TNF receptor signaling pathway ;Ceramide signaling pathway (Consensus)

Recessive Scores

pRec
0.247

Intolerance Scores

loftool
0.861
rvis_EVS
-1.96
rvis_percentile_EVS
1.86

Haploinsufficiency Scores

pHI
0.355
hipred
Y
hipred_score
0.652
ghis
0.611

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.866

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Madd
Phenotype
homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype;

Gene ontology

Biological process
activation of MAPK activity;cell surface receptor signaling pathway;regulation of tumor necrosis factor-mediated signaling pathway;regulation of Rab protein signal transduction;regulation of apoptotic process;regulation of cell cycle;execution phase of apoptosis;regulation of extrinsic apoptotic signaling pathway via death domain receptors;regulation of extrinsic apoptotic signaling pathway
Cellular component
cytoplasm;cytosol;plasma membrane;integral component of membrane
Molecular function
death receptor binding;protein binding;Rab guanyl-nucleotide exchange factor activity;protein kinase activator activity